Advances in the Prediction and Risk Assessment of Lung Cancer-Associated Venous Thromboembolism

Wenjuan Di, Haotian Xu, Ting Xue, Chunhua Ling Department of Respiratory and Critical Care Medicine, The First Hospital Affiliated of Soochow University, Suzhou City, Jiangsu Province, People’s Republic of ChinaCorrespondence: Chunhua LingDepartment of Respiratory and Critical Care Medicine, The Fir...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Di W, Xu H, Xue T, Ling C
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	lung cancer venous thromboembolism risk factor risk assessment model anticoagulation Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/b9efe58bd40d42cf84e2fa08a61f003c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:b9efe58bd40d42cf84e2fa08a61f003c
record_format	dspace
spelling	oai:doaj.org-article:b9efe58bd40d42cf84e2fa08a61f003c2021-11-04T19:00:26ZAdvances in the Prediction and Risk Assessment of Lung Cancer-Associated Venous Thromboembolism1179-1322https://doaj.org/article/b9efe58bd40d42cf84e2fa08a61f003c2021-11-01T00:00:00Zhttps://www.dovepress.com/advances-in-the-prediction-and-risk-assessment-of-lung-cancer-associat-peer-reviewed-fulltext-article-CMARhttps://doaj.org/toc/1179-1322Wenjuan Di, Haotian Xu, Ting Xue, Chunhua Ling Department of Respiratory and Critical Care Medicine, The First Hospital Affiliated of Soochow University, Suzhou City, Jiangsu Province, People’s Republic of ChinaCorrespondence: Chunhua LingDepartment of Respiratory and Critical Care Medicine, The First Hospital Affiliated of Soochow University, No. 188, Shizi Street, Gusu District, Suzhou City, Jiangsu Province, People’s Republic of ChinaTel +86-18351071532Email linchunhua88@hotmail.comAbstract: According to the most recent data from the National Cancer Center, venous thromboembolism (VTE) has unsurprisingly become one of the most common complications in lung cancer. VTE not only interferes with the equilibrium of the clotting system but it also affects tumor progression and prognosis. For the identification of high-risk patients, many clinical risk assessment models have been developed and validated based on the risk factors found in previous studies. In this review, we will summarize advances in prediction and risk assessment of VTE, with a focus on early diagnosis and therapy, reduction of mortality, and the burden of medical costs in lung cancer patients.Keywords: lung cancer, venous thromboembolism, risk factor, risk assessment model, anticoagulationDi WXu HXue TLing CDove Medical Pressarticlelung cancervenous thromboembolismrisk factorrisk assessment modelanticoagulationNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancer Management and Research, Vol Volume 13, Pp 8317-8327 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	lung cancer venous thromboembolism risk factor risk assessment model anticoagulation Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	lung cancer venous thromboembolism risk factor risk assessment model anticoagulation Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Di W Xu H Xue T Ling C Advances in the Prediction and Risk Assessment of Lung Cancer-Associated Venous Thromboembolism
description	Wenjuan Di, Haotian Xu, Ting Xue, Chunhua Ling Department of Respiratory and Critical Care Medicine, The First Hospital Affiliated of Soochow University, Suzhou City, Jiangsu Province, People’s Republic of ChinaCorrespondence: Chunhua LingDepartment of Respiratory and Critical Care Medicine, The First Hospital Affiliated of Soochow University, No. 188, Shizi Street, Gusu District, Suzhou City, Jiangsu Province, People’s Republic of ChinaTel +86-18351071532Email linchunhua88@hotmail.comAbstract: According to the most recent data from the National Cancer Center, venous thromboembolism (VTE) has unsurprisingly become one of the most common complications in lung cancer. VTE not only interferes with the equilibrium of the clotting system but it also affects tumor progression and prognosis. For the identification of high-risk patients, many clinical risk assessment models have been developed and validated based on the risk factors found in previous studies. In this review, we will summarize advances in prediction and risk assessment of VTE, with a focus on early diagnosis and therapy, reduction of mortality, and the burden of medical costs in lung cancer patients.Keywords: lung cancer, venous thromboembolism, risk factor, risk assessment model, anticoagulation
format	article
author	Di W Xu H Xue T Ling C
author_facet	Di W Xu H Xue T Ling C
author_sort	Di W
title	Advances in the Prediction and Risk Assessment of Lung Cancer-Associated Venous Thromboembolism
title_short	Advances in the Prediction and Risk Assessment of Lung Cancer-Associated Venous Thromboembolism
title_full	Advances in the Prediction and Risk Assessment of Lung Cancer-Associated Venous Thromboembolism
title_fullStr	Advances in the Prediction and Risk Assessment of Lung Cancer-Associated Venous Thromboembolism
title_full_unstemmed	Advances in the Prediction and Risk Assessment of Lung Cancer-Associated Venous Thromboembolism
title_sort	advances in the prediction and risk assessment of lung cancer-associated venous thromboembolism
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/b9efe58bd40d42cf84e2fa08a61f003c
work_keys_str_mv	AT diw advancesinthepredictionandriskassessmentoflungcancerassociatedvenousthromboembolism AT xuh advancesinthepredictionandriskassessmentoflungcancerassociatedvenousthromboembolism AT xuet advancesinthepredictionandriskassessmentoflungcancerassociatedvenousthromboembolism AT lingc advancesinthepredictionandriskassessmentoflungcancerassociatedvenousthromboembolism
_version_	1718444674068250624

Advances in the Prediction and Risk Assessment of Lung Cancer-Associated Venous Thromboembolism

Ejemplares similares